Benchmarking Resolution and Recovery of BioResolve™ 1 mm ID C18 RP Columns with MaxPeak™ Premier Technology

Significance of the topic

The development and benchmarking of microflow reversed-phase (RP) columns for proteomics addresses key practical challenges: maximizing sensitivity while minimizing sample and solvent consumption, and avoiding analyte loss due to non-specific adsorption in column hardware. Improvements in column hardware surface chemistry and stationary phase design directly impact peptide recovery, peak shape, chromatographic resolution, and ultimately mass spectrometric identification confidence—critical parameters for quantitative and discovery proteomics workflows.

Objectives and study overview

This study compared the analytical performance of the Waters BioResolve Peptide C18 RP 1.0 mm ID column equipped with MaxPeak Premier (MaxPeak HPS) technology against three commercially available microflow columns of similar dimensions. Using a commercial MassPREP Enolase Digest with Phosphopeptides Mix the authors evaluated peak capacity for non-acidic peptides, recovery and peak shape for acidic and phosphorylated peptides from the first injection, chromatographic reproducibility during conditioning, and the impact of separation quality on MS spectral cleanliness and signal-to-noise. The aim was to determine whether MaxPeak Premier hardware reduces the need for extended column conditioning and improves proteomics data quality in microflow LC–MS workflows.

Methodology

• Sample: Waters MassPREP Enolase Digest with Phosphopeptides Mix, reconstituted in 0.1% formic acid.
• Columns compared:
  • BioResolve Peptide C18 RP, MaxPeak Premier, 1.7 μm, 130 Å BEH, 1.0 × 100 mm (Waters)
  • Column K: core–shell C18, 1.7 μm, 100 Å, 1.0 × 100 mm
  • Column Y: C18, 1.9 μm, 120 Å, 1.0 × 100 mm
  • Column H: core–shell C18, 2.7 μm, 120 Å, 1.5 × 100 mm (larger ID)
• Chromatography: microflow conditions (low μL/min range), 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B), column temperature 60 °C, sample temperature 6 °C, 1 μL injections; gradients adjusted for column ID.
• Mass spectrometry: Waters Xevo G2 (ESI+), low-flow probe, mass range 50–2000 m/z, 1 Hz acquisition, lockmass LeuEnk (556.27658 m/z).
• Performance metrics: 4σ peak capacity calculated for a set of non-acidic peptides, extracted ion chromatograms (XICs) and peak areas for phosphorylated peptides, USP tailing factors for acidic peptides, and comparison of mass spectral signal-to-noise and baseline noise.

Used instrumentation

• ACQUITY Premier UPLC system with ACQUITY Premier UPLC standard tubing and 40 μm ID × 30 in tubing to MS source.
• BioResolve Peptide C18 RP columns with MaxPeak Premier hardware (Waters).
• Xevo G2 mass spectrometer with low-flow ESI probe.
• QuanRecovery vials used for minimized adsorption during sample storage.

Main results and discussion

• Peak capacity: For four non-acidic peptides the BioResolve Peptide column delivered the highest peak capacity among the 1.0 mm ID columns, exceeding Columns K and Y by over 10%. Column H (1.5 mm ID) showed slightly higher peak capacity attributed to reduced post-column dispersion from its larger ID.
• Acidic and phosphopeptide recovery: The BioResolve column recovered all monitored phosphopeptides on the first injection, including a doubly phosphorylated peptide (T43pp) that was poorly or not recovered on the alternative columns. Alternative columns required several injections (conditioning) to approach comparable peak areas, and even after conditioning their peak areas for some phosphopeptides remained below the unconditioned BioResolve performance.
• Peak shape and tailing: On the first injection the BioResolve column produced sharper, less-tailed peaks for acidic and phosphorylated peptides. USP tailing factors for a model phosphopeptide (T19p) were lower on BioResolve versus Columns K and Y even after conditioning; Column H showed the worst initial tailing and required extensive conditioning.
• MS data quality: Cleaner chromatographic separation on the BioResolve column led to cleaner mass spectra with higher intensity for target precursor ions (example: triply charged T35 ion at 625.33 m/z). The signal for that ion was >40% lower on the comparator columns. Column Y also showed column bleed peaks (notably at ~149.04 and 223.06 m/z), elevating baseline noise and complicating spectra.
• Reproducibility and conditioning: MaxPeak Premier hardware minimized secondary interactions with acidic analytes, substantially reducing or eliminating the need for extended column conditioning prior to routine analysis—translating to faster method deployment and higher day‑one reproducibility.

Benefits and practical applications

• Improved sensitivity and identification confidence in microflow proteomics due to higher recovery of acidic and phosphorylated peptides and better peak shapes.
• Faster method readiness: minimal column conditioning reduces hands-on time and accelerates sample-to-data timelines in routine and discovery workflows.
• Reduced solvent consumption and sample requirements inherent to microflow coupled with robust hardware surfaces support green and economical operation for high-throughput labs.
• Cleaner spectra and reduced column bleed facilitate downstream data analysis and reduce false identifications or missed low-abundance species.

Future trends and potential applications

• Wider adoption of engineered low-adsorption hardware (surface passivation/coatings) to improve recovery of labile or acidic analytes across LC–MS workflows, including phosphoproteomics and PTM-focused studies.
• Integration of optimized microflow columns with higher-sensitivity MS platforms, ion mobility, and data‑independent acquisition strategies to boost depth and throughput for large cohort studies and clinical proteomics.
• Development of standardized conditioning and QC metrics for microflow columns to support inter-laboratory reproducibility and method transfer.
• Applications in low-input and single‑cell proteomics where minimizing surface losses is essential for detection of low-abundance peptides.

Conclusion

The BioResolve Peptide C18 RP 1.0 mm ID column with MaxPeak Premier technology demonstrates clear advantages in microflow proteomics: higher peak capacity for non-acidic peptides, substantially improved first-injection recovery and peak shape for acidic and phosphorylated peptides, and cleaner MS spectra with higher signal-to-noise. These benefits reduce the need for prolonged column conditioning, improve reproducibility, and enhance confidence in peptide identification—making the technology well suited for sensitive, high-throughput LC–MS proteomics applications.

References

1. Gao Y., Fillmore T. L., Munoz N., et al. High-Throughput Large-Scale Targeted Proteomics Assays for Quantifying Pathway Proteins in Pseudomonas putida KT2440. Frontiers in Bioengineering and Biotechnology. 2020;8:1–13.
2. Lennon S., Hughes C. J., Muazzam A., et al. High-Throughput Microbore Ultrahigh-Performance Liquid Chromatography-Ion Mobility-Enabled-Mass Spectrometry-Based Proteomics Methodology for the Exploratory Analysis of Serum Samples from Large Cohort Studies. Journal of Proteome Research. 2021;20(3):1705–1715.
3. Berthelette K., Collins C., Walter T. H. Improving Sensitivity and Analytical Method Greenness using MaxPeak Premier 1.0 mm Internal Diameter Columns. Waters Application Note. 720009221; 2026.
4. Hanna C. M., Koza S. M., Addepalli B. Enhanced Recovery and Peak Shape of Acidic Peptides with BioResolve 1 mm ID Columns with MaxPeak Premier Technology. Waters Application Note. 720009231; 2026.